RI-MUHC team takes another step toward precision medicine by targeting a biomarker of CDK4/6 inhibitor efficacy in breast cancer, including triple-negative...
Sylvie Lambert, Marc Martel and Mathieu Roy are emerging leaders in research domains ranging from chronic illnesses...
David Labbé of the RI-MUHC co-leads a new project recently funded by the Marathon of Hope Cancer Centres...